Reliven®

Reliven®

Non-Steroidal Anti-inflammatory Injection for Dogs and Cats

Reliven® 5 mg/mL is a non-steroidal anti-inflammatory injection, with the active ingredient meloxicam. Reliven® is registered for use in dogs and cats.

For the 20 mg/mL Reliven® product registered for cattle, sheep, pigs, and horses, click here.

 

On this page
Technical Information

Meloxicam is a staple analgesic in today’s companion animal practice.

Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, anti-exudative, analgesic and antipyretic effects. It reduces leukocyte infiltration into the inflamed tissue.

Reliven® borrows from Alfaxan® technology to update and improve the formulation for easy syringeability and comfortable administration.

Solubilised in hydroxypropylcyclodextrin (HPCD), Reliven® is easier to syringe and more comfortable to inject.

Technical Information

Active Constituent(s)

5 mg/mL Meloxicam

Indications

Dogs: For alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders. For reduction of post-operative pain and inflammation following orthopaedic and soft tissue surgery in dogs.

Cats: For reduction of pain after surgery. For management of febrile conditions in combination with appropriate antibiotics.

Dosage

Dogs:
Musculoskeletal disorders: Single subcutaneous injection at a dosage of 0.2 mg meloxicam / kg bodyweight (i.e. 0.4 mL / 10 kg bodyweight). An oral meloxicam product should be used for continuation of treatment at a dosage of 0.1 mg meloxicam / kg bodyweight, 24 hours after administration of the injection.
Reduction of post-operative pain: Single intravenous or subcutaneous injection at a dosage of 0.2 mg meloxicam / kg bodyweight (i.e. 0.4 mL / 10 kg bodyweight) before surgery, for example at the time of induction of anaesthesia.

Cats:
Reduction of post-operative pain: Single subcutaneous injection at a dosage of 0.3 mg meloxicam / kg bodyweight (i.e. 0.06 mL / kg bodyweight) directly prior to induction of anaesthesia.
Management of febrile conditions: Single subcutaneous injection at a dosage of 0.3 mg meloxicam / kg bodyweight (i.e. 0.06 mL / kg
bodyweight).

Product Codes

Size Code
20 mL 504210

Are you a veterinarian?

To view our range of veterinary products please confirm that you are a veterinarian and you will be redirected to our product list.